Nothing Special   »   [go: up one dir, main page]

NO165398C - Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater. - Google Patents

Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater.

Info

Publication number
NO165398C
NO165398C NO872831A NO872831A NO165398C NO 165398 C NO165398 C NO 165398C NO 872831 A NO872831 A NO 872831A NO 872831 A NO872831 A NO 872831A NO 165398 C NO165398 C NO 165398C
Authority
NO
Norway
Prior art keywords
nitrofurand
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO872831A
Other languages
English (en)
Other versions
NO872831D0 (no
NO872831L (no
NO165398B (no
Inventor
Philippe Manoury
Jean Binet
Michel Aletru
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO872831D0 publication Critical patent/NO872831D0/no
Publication of NO872831L publication Critical patent/NO872831L/no
Publication of NO165398B publication Critical patent/NO165398B/no
Publication of NO165398C publication Critical patent/NO165398C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO872831A 1986-07-08 1987-07-07 Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater. NO165398C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609886A FR2601368B1 (fr) 1986-07-08 1986-07-08 Derives de nitrofuranne, leur preparation et leur application en therapeutique.

Publications (4)

Publication Number Publication Date
NO872831D0 NO872831D0 (no) 1987-07-07
NO872831L NO872831L (no) 1988-01-11
NO165398B NO165398B (no) 1990-10-29
NO165398C true NO165398C (no) 1991-02-06

Family

ID=9337175

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872831A NO165398C (no) 1986-07-08 1987-07-07 Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater.

Country Status (18)

Country Link
US (1) US4794120A (no)
EP (1) EP0252809A3 (no)
JP (1) JPS6323879A (no)
KR (1) KR880001641A (no)
CN (1) CN87104648A (no)
AU (1) AU594170B2 (no)
CA (1) CA1287049C (no)
DK (1) DK349387A (no)
FI (1) FI873010A (no)
FR (1) FR2601368B1 (no)
HU (1) HU196413B (no)
IL (1) IL83093A (no)
MA (1) MA21029A1 (no)
NO (1) NO165398C (no)
NZ (1) NZ220986A (no)
PT (1) PT85279B (no)
TN (1) TNSN87086A1 (no)
ZA (1) ZA874939B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901423D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
ES2081747B1 (es) * 1993-09-07 1997-01-16 Esteve Labor Dr Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
US6711297B1 (en) * 1998-07-03 2004-03-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and apparatus for dynamic transfer of image data
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0318464D0 (en) * 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318463D0 (en) * 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) * 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) * 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
US7632928B2 (en) * 2004-04-19 2009-12-15 Charm Sciences, Inc Method and antibodies for detecting nitrofuran
GB0710121D0 (en) 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
EP2283006B1 (en) 2008-04-24 2015-02-25 F2G Limited Pyrrole antifungal agents
CN101624376B (zh) 2009-08-19 2011-09-14 沈阳中海药业有限公司 取代酰肼类化合物及其应用
WO2011069039A1 (en) * 2009-12-04 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hydrazone and diacyl hydrazine compounds and methods of use
WO2013048584A2 (en) * 2011-05-24 2013-04-04 Northeastern University Prodrugs for treating microbial infections
CN111096967B (zh) 2014-11-21 2023-03-10 F2G有限公司 抗真菌剂
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
CN107098894B (zh) * 2017-04-25 2019-07-09 西华大学 N-(2-噻吩基)亚甲基-2-氰基-3-杂环基丙烯酰肼类衍生物及其应用
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
CN110590771B (zh) * 2019-09-05 2021-11-12 南通大学 一种[1,5-a]-吡啶并咪唑-1-腈及其化学合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH479615A (de) * 1959-12-24 1969-10-15 Ciba Geigy Verfahren zur Herstellung neuer Methylidenverbindungen
US3424845A (en) * 1967-05-25 1969-01-28 Salsbury Lab 3,5-dinitrosalicylic acid, 5-nitrofurfurylidene hydrazide and compositions containing and methods employing the same for the control of histomoniasis
LU71111A1 (no) * 1974-10-15 1976-08-19

Also Published As

Publication number Publication date
TNSN87086A1 (fr) 1990-01-01
AU594170B2 (en) 1990-03-01
JPS6323879A (ja) 1988-02-01
KR880001641A (ko) 1988-04-25
FR2601368A1 (fr) 1988-01-15
NO872831D0 (no) 1987-07-07
DK349387A (da) 1988-01-09
PT85279A (fr) 1987-08-01
NO872831L (no) 1988-01-11
FI873010A (fi) 1988-01-09
DK349387D0 (da) 1987-07-07
IL83093A0 (en) 1987-12-31
IL83093A (en) 1991-07-18
ZA874939B (en) 1988-03-30
PT85279B (pt) 1990-03-30
EP0252809A3 (fr) 1989-07-19
CN87104648A (zh) 1988-04-13
MA21029A1 (fr) 1988-04-01
US4794120A (en) 1988-12-27
HU196413B (en) 1988-11-28
AU7529387A (en) 1988-01-14
FI873010A0 (fi) 1987-07-07
CA1287049C (en) 1991-07-30
HUT44787A (en) 1988-04-28
NO165398B (no) 1990-10-29
NZ220986A (en) 1989-09-27
FR2601368B1 (fr) 1989-04-07
EP0252809A2 (fr) 1988-01-13

Similar Documents

Publication Publication Date Title
NO165398C (no) Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater.
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO165023C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO161370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO872889L (no) Preparat og fremgangsmaate for stimulering av underjordiske formasjoner.
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO872660D0 (no) Preparat og fremgangsmaate for stimulering av underjordiske formasjoner.
NO171212C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraliner, kromaner og beslektede forbindelser
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO162721C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO165592C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiofener og benzofuraner.
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO882462D0 (no) Fremstilling og bruk av fenolderivater.
NO167284C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater.
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.